Twist Bioscience Corporation (Nasdaq: TWST)

https://www.twistbioscience.com

Twitter: @TwistBioscience

We are leading and rapidly growing synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of our platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. We are leveraging our unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sample (NGS) preparation, and antibody libraries for drug discovery and development. We are also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. We make products for use across many industries including healthcare, industrial chemicals, agriculture and academic research. *

	Start	2013-01-01 established
	Industry	oligo synthesis
	Industry 2	synthetic biotechnology
	Person	LeProust, Emily M. (Twist Bioscience 2013– CEO + Co-Founder before Agilent Director Genomics Application Development)

	Region	San Francisco, CA
	Country	United States (USA)
	Street	455 Mission Bay Blvd. South
	City	94158 San Francisco, CA
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for ï¿½About Sectionï¿½: Twist Bioscience Corporation. (10/30/18). "Press Release: Twist Bioscience Corporation Announces Pricing of Initial Public Offering". San Francisco, CA.

		Record changed: 2020-10-15